A Mitochondrial Lipid Controls How Aging Muscle Changes Fiber Type
Cardiolipin decline in aging muscle triggers a shift toward slow oxidative fibers — and restoring it reverses muscle wasting in mice.
Summary
As we age, skeletal muscle paradoxically accumulates more mitochondria-rich fibers even as mitochondrial function declines. Researchers at the University of Copenhagen and collaborating institutions identified cardiolipin — a lipid unique to mitochondrial membranes — as a key driver of this shift. When cardiolipin synthase was deleted in young mice, replicating the low cardiolipin levels seen in aged muscle, the animals developed age-like changes: a switch from fast glycolytic to slow oxidative muscle fibers, mediated by a signaling pathway from the mitochondria to the nucleus involving estrogen-related receptor gamma. Crucially, restoring cardiolipin levels reversed muscle atrophy and fully rescued premature death in the knockout mice. The findings identify cardiolipin as a potential therapeutic target for sarcopenia and muscle-related diseases, offering a concrete molecular mechanism linking mitochondrial membrane health to functional muscle aging.
Detailed Summary
Aging muscle presents a long-standing paradox: mitochondrial function deteriorates with age, yet aged muscle tends to accumulate more oxidative, mitochondria-dense fiber types. Understanding why this happens — and whether it can be reversed — has major implications for sarcopenia, metabolic health, and longevity.
Researchers used both mouse and human skeletal muscle to show that cardiolipin, a phospholipid found almost exclusively in mitochondrial membranes, is the causal link between mitochondrial dysfunction and age-related fiber-type remodeling. Cardiolipin levels decline in aging muscle, and by using an inducible, muscle-specific deletion of cardiolipin synthase 1 (Crls1) in young mice, the team reproduced hallmark aging changes — including the characteristic shift from fast glycolytic to slow oxidative fibers — without waiting for natural aging to occur.
The mechanism involves retrograde mitochondria-to-nucleus signaling through estrogen-related receptor gamma (ERRγ), a nuclear receptor that promotes reactive oxygen species-sensitive glucose uptake and reroutes glycolytic flux toward antioxidant defense. This adaptive response appears to be the muscle cell's attempt to cope with dysfunctional mitochondria — but it comes at the cost of fiber-type composition and overall muscle mass.
Strikingly, when Crls1 expression was restored in adult knockout mice, cardiolipin levels were reestablished, reversal of muscle atrophy was initiated, and the animals were fully rescued from premature mortality. This demonstrates that the process is not irreversible, raising the possibility that targeting cardiolipin biosynthesis could treat sarcopenia or mitochondrial myopathies in humans.
The identification of a lipid-mediated mitochondrial signaling axis controlling muscle fiber fate is a significant conceptual advance in aging biology, though full effect sizes and the specific human data details require access to the full paper to assess.
Key Findings
- Cardiolipin decline causally drives the shift from fast glycolytic to slow oxidative muscle fibers seen in aging.
- Estrogen-related receptor gamma mediates mitochondria-to-nucleus signaling that remodels fiber type when cardiolipin falls.
- Restoring cardiolipin synthase 1 in adult knockout mice reestablishes cardiolipin, initiates reversal of muscle atrophy, and fully rescues premature mortality.
- The model reproduces key aging hallmarks in young mice, validating cardiolipin as a therapeutic target for sarcopenia.
- ERRγ-driven glycolytic rerouting toward antioxidant defense links low cardiolipin to altered muscle metabolism.
Methodology
The study combined inducible, tissue-specific deletion of cardiolipin synthase 1 (Crls1) in young mice with rescue experiments restoring Crls1 expression in adult knockouts, alongside parallel analysis of aging mouse and human skeletal muscle. Mitochondria-to-nucleus signaling was dissected to identify estrogen-related receptor gamma as the key mediator of fiber-type switching. Both genetic loss-of-function and gain-of-function approaches were used to establish causality.
Study Limitations
The study's full methodological details, effect magnitudes, and the specific characteristics of the human skeletal muscle data cannot be fully evaluated from the abstract. Mouse genetic models with acute Crls1 deletion may not fully recapitulate the gradual, multifactorial cardiolipin decline seen in human aging. The therapeutic window and safety of targeting cardiolipin biosynthesis in humans remain unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: